PhD Scholarship: Anticancer Properties of Low-THC containing Medicinal Cannabis
Thursday, 1 March 2018
Treatments have not changed for the most common and deadly form of blood cancer, acute myeloid leukaemia (AML) in over 40 years.
Treatments have not changed for the most common and deadly form of blood cancer, acute myeloid leukaemia (AML) in over 40 years. Unfortunately, only 24% of AML patients will live 5-years after diagnosis, highlighting the need for better therapies. Medicinal cannabis is effective for treating cancer related pain however, there is strong evidence that cannabis also has anticancer properties. In this project, we will investigate whether low THC hemp is an effective new therapeutic for AML and determine whether it is a safe complementary therapy.
$26,682 p.a. (2017 rate) indexed in January each year for three and a half years. The scholarship is provided by Faculty in-line with our recent successful Fellowship application.
- Hon I or Masters in BioMed/Sci, with a completed research project that employed drug development, biochemistry, analytical chemistry, cell culture techniques
- Be prepared to use animal models.
- This opportunity is available to domestic and international students.
Interested applicants should send an email expressing their interest, including scanned evidence of their academic transcript, CV. These documents should be emailed to Mengna.email@example.com by 5pm, Thursday 1st March 2018.
For more information please contact:
Contact Name: Mengna Chi
Phone: +61 2 4921 5693